Published on 11/10/2006 in the Prospect News Biotech Daily.
New Issue: Thermage raises $42 million in IPO of 6 million shares at $7 each - below reduced guidance
By Ronda Fears
Memphis, Nov. 10 - Thermage, Inc. raised $42 million from its initial public offering of 6 million shares at $7 each - below lowered price talk of $8 to $9 per share, which was cut from $11 to $13 - via lead manager Merrill Lynch & Co.
Hayward, Calif.-based Thermage has developed ThermaCool, a non-invasive treatment of wrinkles approved for commercial sales. Proceeds are slated for marketing, research and to repay its working capital line of credit.
Issuer: | Thermage, Inc.
|
Issue: | Initial public offering
|
Gross proceeds: | $42 million
|
Shares: | 6 million
|
Greenshoe: | 900,000 shares
|
Price: | $7 per share
|
Price talk: | Revised: $8 to $9 per share
|
| Original: $11 to $13 per share
|
Bookrunner: | Merrill Lynch & Co.
|
Co-managers: | Thomas Weisel Partners LLC, Wachovia Securities, C. E. Unterberg, Towbin and Maxim Group LLC
|
Pricing date: | Nov. 9
|
Settlement date: | Nov. 15
|
Stock symbol: | Nasdaq: THRM
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.